Stockreport

Akebia's Valuation Looks Stretched Despite Auryxia's Loss Of Exclusivity [Seeking Alpha]

Akebia Therapeutics, Inc.  (AKBA) 
Last akebia therapeutics, inc. earnings: 3/10 07:49 am Check Earnings Report
US:NASDAQ Investor Relations: ir.akebia.com/investor-relations
PDF Vafseo's market launch shows some promise, but it's a niche product facing competition and high commercialization costs. Auryxia's loss of exclusivity in March 2025 p [Read more]